(Cont.) Convention On The Prohibition Of The Development, Production,
Stockpiling And Use Of Chemical Weapons And On Their Destruction
"United Nations, 1993, pp. 1 - 172"

         (a) The chemical name, structural formula and Chemical Abstracts Service registry number, if assigned;

         (b) The quantity acquired from other State or transferred to other States Parties. For each transfer the quantity, recipient and purpose shall be included.

C.  PRODUCTION

General principles for production

7.  Each State Party, during production under paragraphs 8 to 12 shall assign the highest priority to ensuring the safety of people and to protecting the environment. Each State Party shall conduct such production in accordance with its national standards for safety and emissions.

Single small-scale facility

8.  Each State Party that produces Schedule 1 chemicals for research, medical, pharmaceutical or protective purposes shall carry out the production at a single small-scale facility approved by the State Party, except as set forth in paragraphs 10, 11 and 12.

9.  The production at a single small-scale facility shall be carried out in reaction vessels in production lines not configurated for continuous operation. The volume of such a reaction vessel shall not exceed 100 litres, and the total volume of all reaction vessels with a volume exceeding 5 litres shall not be more than 500 litres.

Other facilities

10.  Production of Schedule 1 chemicals in aggregate quantities not exceeding 10 kg per year may be carried out for protective purposes at one facility outside a single small-scale facility. This facility shall be approved by the State Party.

11.  Production of Schedule 1 chemicals in quantities of more than 100 g per year may be carried out for research, medical or pharmaceutical purposes outside a single small-scale facility in aggregate quantities not exceeding l0 kg per year per facility. These facilities shall be approved by the State Party.

12.  Synthesis of Schedule 1 chemicals for research, medical or pharmaceutical purposes, but not for protective purposes, may be carried out at laboratories in aggregate quantities less than 100 g per year per facility. These facilities shall not be subject to any obligation relating to declaration and verification as specified in Sections D and E.

<125>